These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 26888482)

  • 41. PARS2 and NARS2 mutations in infantile-onset neurodegenerative disorder.
    Mizuguchi T; Nakashima M; Kato M; Yamada K; Okanishi T; Ekhilevitch N; Mandel H; Eran A; Toyono M; Sawaishi Y; Motoi H; Shiina M; Ogata K; Miyatake S; Miyake N; Saitsu H; Matsumoto N
    J Hum Genet; 2017 Apr; 62(5):525-529. PubMed ID: 28077841
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Homozygous EXOSC3 mutation c.92G→C, p.G31A is a founder mutation causing severe pontocerebellar hypoplasia type 1 among the Czech Roma.
    Schwabova J; Brozkova DS; Petrak B; Mojzisova M; Pavlickova K; Haberlova J; Mrazkova L; Hedvicakova P; Hornofova L; Kaluzova M; Fencl F; Krutova M; Zamecnik J; Seeman P
    J Neurogenet; 2013 Dec; 27(4):163-9. PubMed ID: 23883322
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Classification, diagnosis and potential mechanisms in pontocerebellar hypoplasia.
    Namavar Y; Barth PG; Poll-The BT; Baas F
    Orphanet J Rare Dis; 2011 Jul; 6():50. PubMed ID: 21749694
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Olivopontocerebellar atrophy: a case report.
    Pemde HK; Bakhshi S; Kalra V
    Brain Dev; 1995; 17(2):130-2. PubMed ID: 7625548
    [TBL] [Abstract][Full Text] [Related]  

  • 45. EXOSC3 mutations in pontocerebellar hypoplasia type 1: novel mutations and genotype-phenotype correlations.
    Eggens VR; Barth PG; Niermeijer JM; Berg JN; Darin N; Dixit A; Fluss J; Foulds N; Fowler D; Hortobágyi T; Jacques T; King MD; Makrythanasis P; Máté A; Nicoll JA; O'Rourke D; Price S; Williams AN; Wilson L; Suri M; Sztriha L; Dijns-de Wissel MB; van Meegen MT; van Ruissen F; Aronica E; Troost D; Majoie CB; Marquering HA; Poll-Thé BT; Baas F
    Orphanet J Rare Dis; 2014 Feb; 9():23. PubMed ID: 24524299
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Exome sequencing reveals a novel Moroccan founder mutation in SLC19A3 as a new cause of early-childhood fatal Leigh syndrome.
    Gerards M; Kamps R; van Oevelen J; Boesten I; Jongen E; de Koning B; Scholte HR; de Angst I; Schoonderwoerd K; Sefiani A; Ratbi I; Coppieters W; Karim L; de Coo R; van den Bosch B; Smeets H
    Brain; 2013 Mar; 136(Pt 3):882-90. PubMed ID: 23423671
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clinical and molecular characteristics of newly reported mitochondrial disease entity caused by biallelic PARS2 mutations.
    Ciara E; Rokicki D; Lazniewski M; Mierzewska H; Jurkiewicz E; Bekiesińska-Figatowska M; Piekutowska-Abramczuk D; Iwanicka-Pronicka K; Szymańska E; Stawiński P; Kosińska J; Pollak A; Pronicki M; Plewczyński D; Płoski R; Pronicka E
    J Hum Genet; 2018 Apr; 63(4):473-485. PubMed ID: 29410512
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Molecular and neuroimaging findings in pontocerebellar hypoplasia type 2 (PCH2): is prenatal diagnosis possible?
    Graham JM; Spencer AH; Grinberg I; Niesen CE; Platt LD; Maya M; Namavar Y; Baas F; Dobyns WB
    Am J Med Genet A; 2010 Sep; 152A(9):2268-76. PubMed ID: 20803644
    [TBL] [Abstract][Full Text] [Related]  

  • 49. GRID2 mutations span from congenital to mild adult-onset cerebellar ataxia.
    Coutelier M; Burglen L; Mundwiller E; Abada-Bendib M; Rodriguez D; Chantot-Bastaraud S; Rougeot C; Cournelle MA; Milh M; Toutain A; Bacq D; Meyer V; Afenjar A; Deleuze JF; Brice A; Héron D; Stevanin G; Durr A
    Neurology; 2015 Apr; 84(17):1751-9. PubMed ID: 25841024
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Monoallelic and Biallelic Variants in EMC1 Identified in Individuals with Global Developmental Delay, Hypotonia, Scoliosis, and Cerebellar Atrophy.
    Harel T; Yesil G; Bayram Y; Coban-Akdemir Z; Charng WL; Karaca E; Al Asmari A; Eldomery MK; Hunter JV; Jhangiani SN; Rosenfeld JA; Pehlivan D; El-Hattab AW; Saleh MA; LeDuc CA; Muzny D; Boerwinkle E; ; Gibbs RA; Chung WK; Yang Y; Belmont JW; Lupski JR
    Am J Hum Genet; 2016 Mar; 98(3):562-570. PubMed ID: 26942288
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Diagnostic utility of whole exome sequencing in patients showing cerebellar and/or vermis atrophy in childhood.
    Ohba C; Osaka H; Iai M; Yamashita S; Suzuki Y; Aida N; Shimozawa N; Takamura A; Doi H; Tomita-Katsumoto A; Nishiyama K; Tsurusaki Y; Nakashima M; Miyake N; Eto Y; Tanaka F; Matsumoto N; Saitsu H
    Neurogenetics; 2013 Nov; 14(3-4):225-32. PubMed ID: 24091540
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Subdural effusions and lack of early pontocerebellar hypoplasia in siblings with RARS2 mutations.
    Kastrissianakis K; Anand G; Quaghebeur G; Price S; Prabhakar P; Marinova J; Brown G; McShane T
    Arch Dis Child; 2013 Dec; 98(12):1004-7. PubMed ID: 24047924
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clinical and genetic analysis of infants with pontocerebellar hypoplasia type 6 caused by RARS2 variations.
    Zhao S; Lian R; Jin L; Li M; Jia T; Xu F; Du K; Wang L; Guo Q; Dong Y
    Epilepsia Open; 2024 Feb; 9(1):250-257. PubMed ID: 38009286
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Infantile and childhood onset PLA2G6-associated neurodegeneration in a large North African cohort.
    Romani M; Kraoua I; Micalizzi A; Klaa H; Benrhouma H; Drissi C; Turki I; Castellana S; Mazza T; Valente EM; Gouider-Khouja N
    Eur J Neurol; 2015 Jan; 22(1):178-86. PubMed ID: 25164370
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A syndrome of olivopontocerebellar atrophy and deafness with onset in infancy.
    Pratap-Chand R; Gururaj AK; Dilip-Kumar S
    Acta Neurol Scand; 1995 Feb; 91(2):133-6. PubMed ID: 7785423
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The very low density lipoprotein receptor-associated pontocerebellar hypoplasia and dysmorphic features in three Turkish patients.
    Sonmez FM; Gleeson JG; Celep F; Kul S
    J Child Neurol; 2013 Mar; 28(3):379-83. PubMed ID: 22532556
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Mitochondrial
    Langer Y; Aran A; Gulsuner S; Abu Libdeh B; Renbaum P; Brunetti D; Teixeira PF; Walsh T; Zeligson S; Ruotolo R; Beeri R; Dweikat I; Shahrour M; Weinberg-Shukron A; Zahdeh F; Baruffini E; Glaser E; King MC; Levy-Lahad E; Zeviani M; Segel R
    J Med Genet; 2018 Sep; 55(9):599-606. PubMed ID: 29764912
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Neuropathologic features of pontocerebellar hypoplasia type 6.
    Joseph JT; Innes AM; Smith AC; Vanstone MR; Schwartzentruber JA; Bulman DE; Majewski J; Daza RA; Hevner RF; Michaud J; Boycott KM;
    J Neuropathol Exp Neurol; 2014 Nov; 73(11):1009-25. PubMed ID: 25289895
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Exome sequencing reveals mutated SLC19A3 in patients with an early-infantile, lethal encephalopathy.
    Kevelam SH; Bugiani M; Salomons GS; Feigenbaum A; Blaser S; Prasad C; Häberle J; Baric I; Bakker IM; Postma NL; Kanhai WA; Wolf NI; Abbink TE; Waisfisz Q; Heutink P; van der Knaap MS
    Brain; 2013 May; 136(Pt 5):1534-43. PubMed ID: 23482991
    [TBL] [Abstract][Full Text] [Related]  

  • 60. New subtype of PCH1C caused by novel EXOSC8 variants in a 16-year-old Spanish patient.
    Rodríguez-García ME; Cotrina-Vinagre FJ; Bellusci M; Merino-López A; Chumilla-Calzada S; García-Silva MT; Martínez-Azorín F
    Neuromuscul Disord; 2021 Aug; 31(8):773-782. PubMed ID: 34210538
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.